Quality of voice after radiotherapy in early vocal cord cancer

Expert Review of Anticancer Therapy

Volumn 10, Issue 9, 2010, Pages 1381-1388

  Waghmare, Chaitali M ^a   Agarwal, Jaiprakash ^b   Bachher, Gurmit K ^b  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

early vocal cord cancer; quality of voice; radiotherapy

Indexed keywords

AGE; ANTERIOR COMMISSURE; CANCER RADIOTHERAPY; CIGARETTE SMOKING; CLINICAL ASSESSMENT; HOARSENESS; HUMAN; LARYNX CANCER; LARYNX SURGERY; PASSIVE SMOKING; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SPEECH REHABILITATION; SPEECH THERAPY; VOCAL CORD; VOCAL CORD DISORDER; VOCALIZATION; VOICE; XEROSTOMIA;

GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; NEOPLASM STAGING; SMOKING; VOCAL CORDS; VOICE QUALITY;

EID: 77956695704     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.126     Document Type: Review

References (54)

1. Parkin M, Bray F, Feraly J et al. Global cancer statistics 2002. CA Cancer J. Clin. 55, 74-108 (2005).
2. Pradhan SA, Pai PS, Neeli SI et al. Transoral laser surgery for early glottic cancers. Arch. Otolaryngol. Head Neck Surg. 129, 623-625 (2003).
3. Ogura JH, Dessions DG, Spector GJ et al. Analysis of surgical therapy for epidermoid carcinoma of the laryngeal glottis. Laryngoscope 85, 1298-1307 (1975).
4. Mohr RM, Quenelle DJ, Shumrick DA et al. Vertical frontolateral laryngectomy. Indications, technique and results. Arch. Otolaryngol. 10, 384-395 (1983).
5. Piquet J, Chevalier D. Subtotal laryngectomy with crico-hyoido-epiglotto- pexy for the treatment of extended glottic cancer. Am. J. Surg. 162(4), 357-361 (1991).
6. Neel HB, Devine KD, DeSanto LW et al. Laryngofssure and cordectomy of early cordal carcinoma. Otolaryngol. Head Neck Surg. 88, 79-84 (1980).
7. Remade M, Eckel HE. Suggested classifcation of endoscopic laryngeal oncological surgery, head and neck oncology. Curr. Opin. Otolaryngol. Head Neck Surg. 8(2), 122-129 (2000).
8. Mendenhall WM, Riggs CE Jr, Cassisi NJ. Treatment of head and neck cancer. In: Cancer Principles and Practice of Oncology. Part I (7th Edition). Lippincott Williams & Wilkins, PA, USA, 699 (2005).
9. Lefebvre JL. Laryngeal preservation in head and cancer: a multidisciplinary approach. Lancet Oncol. 7(9), 747-755 (2006).
10. Spector JC, Sessions DG, Chao KC et al. Stage I [T1 N0 M0] squamous cell carcinoma of laryngeal glottis. Therapeutic results and voice preservation. Head Neck 21(8), 707-717 (1999).
11. Mendenhall WM, Werning JW, Russell WH et al. Management of T1-T2 glottic cancer. Cancer 100(9), 1786-1792 (2004).
12. Van Gogh CDL, Verdonck-de Leeuw IM, Boon-Kamma BA, Langendijk JA, Kuik DJ, Mahieu HF. A screening questionnaire for voice problems after treatment for early glottic cancer. Int. J. Radiat. Oncol. Biol. Phys. 62(3), 700-705 (2005).
13. Cohen SM. Voice related quality of life in T1 glottic cancers: irradiation versus endoscopic excision. A metaanalysis. Otol. Rhinol. Laryngol. 115(8), 581-586 (2006).
14. Tamura E, Kitahara S, Ogura M, Kohno N. Voice quality after laser surgery or radiotherapy for T1 glottic carcinoma. Laryngoscope 113(5), 910-914 (2003).
15. Wedman J, Heimdal JH, Elstad I et al. Voice results in patients with T1a glottis cancers treated by RT or endoscopic measures. Eur. Arch. Otorhinolaryngol. 259(10), 547-550 (2002).
16. Goor KM, Peeters AJ, Mahieu HF et al. Cordectomy by CO laser and radiotherapy for small T1a glottis carcinomas; costs, local control, survival, quality of life and voice quality. Head Neck 29 (2), 128-136 (2007).
17. Rydell R, Schalen L, Fex S et al. Voice evaluation before and after laser excision versus radiotherapy of T1a glottic cancer. Acta Otolaryngol. 115(4), 560-565 (1995).
18. McGuirt WF, Blalock D, Koufman JA et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch. Otolaryngol. Head Neck Surg. 120, 951-955 (1994).
19. Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med. 29(4), 305-313 (2001).
20. Stoekli SJ, Guidicelli M, Schneider A et al QOL after treatment for early laryngeal cancer. Eur. Arch. Otorhinolaryngol. 258(2), 96-99 (2000).
21. Mendenhall WM, Riggs CE Jr, Cassisi NJ. Treatment of head and neck cancer. In: Cancer Principles and Practice of Oncology. Part I (7th Edition). Lippincott Williams & Wilkins, PA, USA, 697 (2005).
22. Radiation Pathology. Fajardo LF, Anderson RE, Berthrong M (Eds). Oxford University Press, Oxford, UK (2001).
23. Keen M, Harwood AR, Bryce DP et al A histopathological study of radionecrosis in laryngeal carcinoma. Laryngoscope 92, 173-180 (1982).
24. Harwood AR, Tierie A. Radiotherapy of early glottic carcinoma. II. Int. J. Radiat. Oncol. Biol. Phys. 5, 477-482 (1979).
25. Deore SM, Supe SJ, Sharma V et al. The predictive role of bioeffect dose models in the radiation induced late effects in glottic cancers. Int. J. Radiat. Oncol. Biol. Phys. 23(2), 281-284 (1992).
26. Taylor JM, Mendenhall WM, Lavey RS et al. Dose, time and fraction size issues in head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 22, 3-11 (1992).
27. Lidegran M, Domeij S, Dahlquist A et al. Irradiation infuences the expression of substance P and enkephalin in the rat larynx. Cell Tissue Res. 279, 55-63 (1995).
28. Lidegran M, Kjorell U, Henriksson R et al. Bombesin like immunoreactivity in the rat larynx: increased in response to radiation. Regul. Pept. 55, 321-330 (1995).
29. Goodrich WA, Lenz M. Laryngeal chondronecrosis following roentgen therapy. Am. J. Roengenol. 60, 22-28 (1948).
30. 2 laser cordectomy. Acta Otorhinolaryngol. 24, 267-274 (2004).
31. Lehman JJ, Bless DM, Brandenburg JH et al. An objective assessment of voice production after radiation therapy for stage I squamous cell carcinoma of the glottis. Otolaryngol. Head Neck Surg 98(2), 121-129 (1988).
32. Jacobson BH, Johnson A, Grywalski C et al. The Voice Handicap Index: development and validation. Am. J. Speech Lang. Pathol. 6(3), 66-70 (1997).
33. Hogikyan ND. Validation of instrument to measure voice related quality of life. J. Voice 13, 557 (1999).
34. Ma EP, Yiu EM. Voice activity and participation profle assessing the impact of voice disorders on daily leaving. J. Speech Lang. Hear. Res. 44, 511-524 (2001).
35. Deary IJ. Vio SS, a patient derived voice symptom scale. J. Psychosom. Res. 54, 483 (2003).
36. Hirano M. Clinical Examination of Voice. Springer Verlag, NY, USA, 50 (1981).
37. American Speech Language Hearing Association, Special Interest Division 3. Voice and Voice Disorders (2003).
38. Lever J, Mackenzie Beck J. Vocal Profle Analysis. Queen Margaret College, University of Edinburgh, Edinburgh, UK (1991).
39. Agarwal JP, Baccher GK, Waghmare CM et al. Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy. Radiother. Oncol. 90, 177-182 (2009).
40. Stoicheff ML. Voice following radiotherapy. Laryngoscope 85(4), 608-618 (1975).
41. Verdonck-de Leeuw IM, Hilgers FJ, Keus RB et al. Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope 109, 241-248 (1999).
42. Guimarães I, Abberton E. Health and voice quality in smokers: an exploratory investigation. Logoped. Phoniatr. Vocol. 30(3), 185-191 (2005).
43. Rovirosa A, Martínez-Celdrán E, Ortega A et al. Acoustic analysis after radiotherapy in T1 vocal cord carcinoma: a new approach to the analysis of voice quality. Int. J. Radiat. Oncol. Biol. Phys. 47(1), 73-79 (2000).
44. Harrison LB, Solomon B, Miller S et al. Prospective computer-assisted voice analysis for patients with early stage glottic cancer: a preliminary report of the functional result of laryngeal irradiation. Int J. Radiat. Oncol. Biol. Phys. 19(1), 123-127 (1999).
45. Harrison LB, Soloman B, Miller S et al. Prospective computer assisted voice analysis for patients with early stage glottic cancer: a preliminary report of functional results of laryngeal irradiation. Int. J. Radiat. Oncol. Biol. Phys. 19(1), 123-127 (1990).
46. Aref A, Dworkin J, Devi S, Denton L, Fontanesi J. Objective evaluation of the quality of voice following radiation therapy for T1 glottic cancer. Radiother. Oncol. 45, 149-153 (1997).
47. Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope 104(3), 294-299 (1994).
48. Jong LR, Ah-Young K, Moon JC et al. Xerostomia following radiotherapy of the head and neck affects vocal function. J. Clin. Oncol. 23(13), 3016-3023 (2005).
49. Fung K, Yoo J, Leeper H et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 111, 1920-1924 (2001).
50. Fisher KV, Lignon J, Sobecks JL et al. Phonatory effects of body fuid removal. J. Speech Lang. Hear. Res. 44, 354-367 (2001).
51. Tetsuo A, Tetsuo N, Yoshizumi K et al. Radiation therapy for T2NO laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. Int. J. Radiat. Oncol. Biol. Phys. 64(4), 995-1001 (2006).
52. Van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA et al. The effcacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer 106(1), 95-105 (2006).
53. Hirano M. Morphological structure of the vocal cord as a vibrator and its its variations. Folia Phoniatr. 26, 89-94 (1974).
54. Hirano M, Mtsuo K, Kakita Y et al. Vibratory behavior vs structure of vocal fold. In: Vocal Fold Physiology. Titze I, Scherer R (Eds). Denver Center for the Performing Arts, CO, USA, 26-40 (1983).